Literature DB >> 18482314

Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.

P Y Basak1, A K Adiloglu, I G Koc, T Tas, V B Akkaya.   

Abstract

BACKGROUND: Recent observations established the role of altered cellular immunity and autoimmune hypothesis in the pathogenesis of vitiligo. There have been several reports discussing T-cell and natural killer (NK) cell populations, but NK cell receptors were not evaluated in vitiligo.
OBJECTIVE: The purpose of this investigation was to assess the role of T and NK cells as well as activatory and inhibitory NK cell receptor alterations in the pathogenesis of vitiligo and whether any aberrations were correlated with clinical findings of the disease. PATIENTS/
METHODS: Fifty-three patients with non-segmental vitiligo and 45 age- and sex-matched healthy controls were enrolled in the study. The percentages of lymphocytes, granulocytes, monocytes and CD3, CD4, CD8, CD14, CD16, CD56, CD45, CD45RA, CD54RO, CD28, CD80, CD94, CD158a, KIR3DL-1 receptors as well as CD94, CD158a, KIR3DL-1 receptors on CD16(+) cells were detected by using flow cytometry. The patient and control groups were compared in terms of the results of flow cytometric analysis, and the results were assessed regarding the type and activity of vitiligo.
RESULTS: The percentages of CD16(+)CD56(+), CD3(+)CD16(+)CD56(+), CD8(+) and CD45RO(+) cells were significantly increased in vitiligo group compared with the controls. No difference was detected between the patients and control groups in percentages of CD3(+), CD4(+), CD3(-)CD16(+)CD56(+), CD28(+), CD45(+), CD45RA(+), CD94(+), CD158a(+) and KIR3DL-1(+) cells. The percentage of CD16(+)CD158a(+) cells was significantly decreased in a randomized selected group of vitiligo patients. There were no differences in percentage expression of studied cell surface antigens between patients in the active or stable period. CD3(+) cells were significantly increased in generalized form, and CD45RO(+) cells were significantly increased in acral/acrofacial form when compared with the other types of vitiligo.
CONCLUSIONS: These results indicate further evidence for T and NK cell abnormalities in non-segmental vitiligo. The present data show that NK cell activation may be responsible in the pathogenesis of vitiligo in conformity with decreased inhibitory and increased activatory NK cell receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482314     DOI: 10.1111/j.1468-3083.2008.02681.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

Review 2.  Myron Gordon Award paper: Microbes, T-cell diversity and pigmentation.

Authors:  I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2021-01-27       Impact factor: 4.159

Review 3.  Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci.

Authors:  Changbing Shen; Jing Gao; Yujun Sheng; Jinfa Dou; Fusheng Zhou; Xiaodong Zheng; Randy Ko; Xianfa Tang; Caihong Zhu; Xianyong Yin; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Genet       Date:  2016-02-01       Impact factor: 4.599

Review 4.  Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.

Authors:  Katia Boniface; Thierry Passeron; Julien Seneschal; Meri K Tulic
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

Review 5.  Current Concepts of Vitiligo Immunopathogenesis.

Authors:  Nika Hlača; Tina Žagar; Marija Kaštelan; Ines Brajac; Larisa Prpić-Massari
Journal:  Biomedicines       Date:  2022-07-08

6.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo.

Authors:  Asmaa Gaber Abdou; Alaa Maraee; Hossam Yassien; Mona Sarhan
Journal:  J Pathol Transl Med       Date:  2018-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.